Efficacy News and Research

RSS

Novel compound inhibits SARS-CoV-2 replication by binding a genome target

Researchers assessed the biodistribution and safety of SBCoV202, a novel antiviral agent based on antisense technology that can specifically and effectively bind to the SARS-CoV-2 genome target to inhibit SARS-CoV-2 replication.

27 Jul 2022

Study shows the efficacy of Yoga of Immortals mobile app for urinary incontinence

People with loss of urinary control who used the Yoga of Immortals mobile app – a globally used app that combines specific yogic postures in the Sanatan tradition with breathing exercises, sound therapy and meditation – found significant improvement in the frequency and severity of urine leaks at four weeks of practice, according to a Rutgers study.

26 Jul 2022

Study confirms efficacy of molnupiravir against COVID in a real-life cohort

Researchers report the efficacy and safety of molnupiravir in treating COVID-19.

26 Jul 2022

SLU and industry partners report the first effective drug to treat rare, genetic liver disease

Researchers at Saint Louis University's School of Medicine, in collaboration with Arrowhead Pharmaceuticals and Takeda Pharmaceuticals, report the first effective drug to treat a rare, genetic liver disease that formerly could only be treated with a liver transplant.

26 Jul 2022

Using CRISPR to Lift the Lid on Probiotics

In this interview, we speak to Echo Pan, a Ph.D. student from North Carolina State University about her latest research that used CRISPR to uncover more on probiotics.

26 Jul 2022

New AI technology may aid in the discovery of therapeutic agents for neurodegenerative disorders

A research group from Nagoya University in Japan has developed an artificial intelligence for analyzing cell images that uses machine learning to predict the therapeutic effect of drugs.

25 Jul 2022

Researchers report ‘hybrid immune damping’ following SARS-CoV-2 Omicron infection

Researchers explore the impact of differential immune imprinting patterns in individuals vaccinated against COVID-19 with a history of prior infection.

25 Jul 2022

How SARS-CoV-2 Omicron spike mutations contribute to increased infectivity

Researchers study the functional impact of Omicron mutations.

25 Jul 2022

A VSV-based COVID vaccine effective against SARS-CoV-2 variants

A new study discusses the development of recombinant vesicular stomatitis virus COVID-19 vaccines.

25 Jul 2022

Bivalent mRNA vaccine induces powerful antibody response to SARS-CoV-2 Omicron subvariants

Researchers discuss the development and efficacy of a bivalent mRNA vaccine against emerging variants such as BA.2.12.1, BA.4, or BA.5.

25 Jul 2022

Why Omicron is more infectious than other SARS-CoV-2 variants

Researchers describe SARS-CoV-2 Omicron mutations and their impact on neutralization and infectivity.

25 Jul 2022

Insights into molecular folding of AAT protein will help develop new therapies for alpha-1 antitrypsin deficiency

In a major new development in the quest to develop better gene therapies with which to treat a host of diseases, researchers at the University of Massachusetts Amherst and UMass Chan Medical School recently announced that they have mapped the expression and maturation of the protein alpha-1 antitrypsin (AAT) with unprecedented clarity.

25 Jul 2022

SARS-CoV-2 oral vaccine candidate found to induce neutralizing mucosal IgA

A new study reported the outcomes of a clinical trial evaluating the oral vaccine candidate against SARS-CoV-2 developed by Vaxart.

25 Jul 2022

What is the role of psychedelic drugs in the treatment of psychiatric disorders?

A new study aimed to determine the clinical applications of psychedelic drugs along with psychedelic-assisted therapy for different psychiatric disorders.

25 Jul 2022

Scientists identify papain-like protease inhibitor against COVID-19

In a new study, researchers identified a papain-like protease inhibitor for the treatment of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections.

25 Jul 2022

IU researchers evaluate the efficacy of a failed clinical trial drug for Alzheimer's using rigorous pipeline

Most drugs developed to treat Alzheimer's disease have for years been ineffective in clinical trials. Researchers from Indiana University School of Medicine recently evaluated the efficacy of a failed clinical trial drug using their rigorous pipeline.

25 Jul 2022

Research reveals molecular clues associated with traumatic brain injury

New research led by scientists at Arizona State University has revealed some of the first detailed molecular clues associated with one of the leading causes of death and disability, a condition known as traumatic brain injury (TBI).

23 Jul 2022

Researchers discover a ‘weak spot’ that makes multi-drug resistant tumors vulnerable

One of the greatest challenges facing cancer researchers is to understand why some patients don't respond to treatments.

22 Jul 2022

New biomimetic formulation developed to tackle glioblastoma multiforme

Glioblastoma multiforme (GBM) is an aggressive brain cancer with a poor prognosis and few treatment options. New and effective approaches for GBM treatment are therefore urgently needed.

22 Jul 2022

Antibodies' neutralization efficacy against Omicron variants BA.1 And BA.2 wanes rapidly, study finds

The Omicron variant of the SARS-CoV-2 virus was first detected in South Africa in November 2021. The high level of infectiousness of the virus and its ability to quickly spawn additional variants has also been observed in Germany: Since January 2022 the Omicron variant BA.1 has dominated here, followed in subsequent months by the variant BA.2.

22 Jul 2022

Efficacy News and Research

Novel compound inhibits SARS-CoV-2 replication by binding a genome target

Study shows the efficacy of Yoga of Immortals mobile app for urinary incontinence

Study confirms efficacy of molnupiravir against COVID in a real-life cohort

SLU and industry partners report the first effective drug to treat rare, genetic liver disease

Using CRISPR to Lift the Lid on Probiotics

New AI technology may aid in the discovery of therapeutic agents for neurodegenerative disorders

Researchers report ‘hybrid immune damping’ following SARS-CoV-2 Omicron infection

How SARS-CoV-2 Omicron spike mutations contribute to increased infectivity

A VSV-based COVID vaccine effective against SARS-CoV-2 variants

Bivalent mRNA vaccine induces powerful antibody response to SARS-CoV-2 Omicron subvariants

Why Omicron is more infectious than other SARS-CoV-2 variants

Insights into molecular folding of AAT protein will help develop new therapies for alpha-1 antitrypsin deficiency

SARS-CoV-2 oral vaccine candidate found to induce neutralizing mucosal IgA

What is the role of psychedelic drugs in the treatment of psychiatric disorders?

Scientists identify papain-like protease inhibitor against COVID-19

IU researchers evaluate the efficacy of a failed clinical trial drug for Alzheimer's using rigorous pipeline

Research reveals molecular clues associated with traumatic brain injury

Researchers discover a ‘weak spot’ that makes multi-drug resistant tumors vulnerable

New biomimetic formulation developed to tackle glioblastoma multiforme

Antibodies' neutralization efficacy against Omicron variants BA.1 And BA.2 wanes rapidly, study finds

Industry Focus eBook - Forensics & toxicology (2nd edition) eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News